Immunocytochemical detection of the p170 multidrug resistance (MDR) and the p53 tumor suppressor gene proteins in human breast cancer cells: Clinical and therapeutical significance

Anticancer Research

Volumn 17, Issue 2B, 1997, Pages 1311-1318

  Bodey, Bela ^a,f   Bodey Jr , Bela ^a   Gröger, Angela M ^b   Luck, James V ^c   Siegel, Stuart E ^d   Taylor, Clive R ^a   Kaiser, Hans E ^b,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

^c JOINT REPLACEMENT INSTITUTE   (United States)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f NONE   (United States)

Author keywords

Antigen detection; Antigen retrieval; Immunocytochemistry; Immunophenotype (IP); Mouse anti human monoclonal antibodies (MoABs); Multidrug resistance (MDR); p170 glycoprotein (MDR Protein); p53 tumor suppressor gene product; Wild type and mutant p53

Indexed keywords

ANTHRACYCLINE; CYTOTOXIC AGENT; GLYCOPROTEIN; MONOCLONAL ANTIBODY; PROTEIN P53; VINCA ALKALOID;

ARTICLE; BREAST CANCER; CELL DIFFERENTIATION; CELL NUCLEUS; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; MEMBRANE TRANSPORT; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ATP-BINDING CASSETTE TRANSPORTERS; BREAST NEOPLASMS; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030894068     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Ali IU, Lidercau R, Theillet C, Callahan R: Reduction of homozygosity of genes on chromosome 11 in human breast neoplasia. Science 238: 185-188, 1987.
2. Winqvist R, Mannermaa A, Alavaikko M, Blanco G, Kiviniemi H, Taskinen PJ, Newsham I, Cavenee W: Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors. Cancer Res 53: 4486-4488, 1993.
3. Carter SL, Negrini M, Baffa R, Gillum DR, Rosenberg AL, Schwartz GF, Croce CM: Loss of heterozygosity at 11q22-q23 in breast cancer. Cancer Res 54: 6270-6274, 1994.
4. Hampton G, Mannermaa A, Winqvist R, Alavaikko M, Blanco G, Taskinen PJ, Kiviniemi H, Newsham I, Cavernee W, Evans G: Loss of heterozygosity in sporadic human breast carcinoma a common region between 11q22 and 11q23.3. Cancer Res 54: 4586-4589, 1994.
5. Winqvist R, Hampton G, Mannermaa A, Blanco G, Alavaikko M, Kiviniemi H, Taskinen PJ, Evans GA, Wright FA, Newsham I, Cavernee WK: Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res 55: 2660-2664, 1995.